Thrombocytopenia Caused By Inherited Haematopoietic Transcription Factor Mutation: Clinical Phenotypes and Diagnostic Considerations

Thrombocytopenia Caused By Inherited Haematopoietic Transcription Factor Mutation: Clinical Phenotypes and Diagnostic Considerations

July 28, 2016 at 8:22 AM 0 comments

David J. Rabbolini, Christopher M. Ward, *William S. Stevenson Department of Haematology and Transfusion Medicine, Royal North Shore Hospital; Northern Blood Research Centre, Kolling Institute of Medical Research, University of Sydney, Sydney, Australia *Correspondence to william.stevenson@sydney.edu.au Disclosure: The authors have declared no conflicts of interest. Received: 10.03.16 Accepted: 24.06.16 Citation:Read More

The Relative Contributions of Germline Variation, Epimutation, and Somatic Mutation to Paediatric Leukaemia Predisposition

The Relative Contributions of Germline Variation, Epimutation, and Somatic Mutation to Paediatric Leukaemia Predisposition

July 28, 2016 at 8:21 AM 0 comments

*Todd E. Druley1,2 1. Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA 2. Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA *Correspondence to druley_t@wustl.edu Disclosure: The author has declared no conflicts of interest. Received: 22.03.16 Accepted: 08.06.16 Citation:Read More

Current Management of Adult Acute Lymphoblastic Leukaemia: Emerging Insights and Outstanding Questions

Current Management of Adult Acute Lymphoblastic Leukaemia: Emerging Insights and Outstanding Questions

July 28, 2016 at 8:20 AM 0 comments

*Xavier Thomas, Caroline Le Jeune Hematology Department, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France *Correspondence to xavier.thomas@chu-lyon.fr Disclosure: The authors have declared no conflicts of interest. Received: 21.03.16 Accepted: 28.06.16 Citation: EMJ Hematol. 2016;4[1]:117-128. Abstract Less than 50% of patients with adult acute lymphoblastic leukaemia (ALL)Read More

Management of Children With Sickle Cell Disease in Europe: Current Situation and Future Perspectives

Management of Children With Sickle Cell Disease in Europe: Current Situation and Future Perspectives

July 28, 2016 at 8:19 AM 0 comments

*Raffaella Colombatti, Laura Sainati Veneto Region Reference Center for the Diagnosis and Management of Sickle Cell Disease in Childhood, Clinic of Pediatric Hematology Oncology, Department of Child and Maternal Health, Azienda Ospedaliera-University of Padova, Padova, Italy *Correspondence to rcolombatti@gmail.com Disclosure: The authors have declared no conflicts of interest. Received: 22.02.16Read More

Advancing Our Clinical Perspectives in Haematology: What Is Your Approach?

Advancing Our Clinical Perspectives in Haematology: What Is Your Approach?

June 16, 2016 at 8:30 AM 0 comments

Summary of presentations from the 11th New Horizons in Haematology conference which took place on 11th March 2016 and was webcast live to moderated audiences in Hong Kong, Italy, Japan, Russia, South Africa, and Spain, and to individuals throughout the world Moderator: Sarah Jarvis1 Speakers: Gunnar Birgegård,2 Tamara Lado Cives,3Read More

Thrombosis in Haematological Disorders: Tailored Management Approaches

Thrombosis in Haematological Disorders: Tailored Management Approaches

July 30, 2015 at 9:03 AM 0 comments

Summary of presentations from the Alexion-supported satellite symposium held at the 20th Congress of the European Hematology Association (EHA) on 11th-14th June 2015, Vienna, Austria Chairperson: Anna Falanga1 Speakers: T. Sakari Jokiranta,2 Anita Hill3 1. Hospital Papa Giovanni XXIII, Bergamo, Italy 2. University of Helsinki, Helsinki, Finland 3. Leeds TeachingRead More

Why Biosimilars Matter: An Innovative Solution to Improve Patient Access

Why Biosimilars Matter: An Innovative Solution to Improve Patient Access

July 30, 2015 at 9:03 AM 0 comments

Summary of presentations from the Sandoz-supported satellite symposium held at the 20th Congress of the European Hematology Association (EHA), Vienna, Austria, on 13th June 2015 Chairperson: Felix Keil1 Speakers: Mark McCamish,2 Robin Foà,3 Karen Van Rassel4 1. Hanusch Krankenhaus der Wiener Gebietskrankenkasse, Vienna, Austria 2. Sandoz, Holzkirchen, Germany 3. Hematology,Read More

Perspectives on the Treatment of Mantle Cell Lymphoma and Follicular Lymphoma in 2015 and Beyond

Perspectives on the Treatment of Mantle Cell Lymphoma and Follicular Lymphoma in 2015 and Beyond

July 30, 2015 at 9:02 AM 0 comments

Summary of presentations from the Celgene satellite symposium, held at the 20th Congress of the European Hematology Association (EHA), Vienna, Austria, on 11th June 2015 Chairpersons: Martin Dreyling,1 Gilles Salles2 Speakers: Paolo Corradini,3 Jehan Dupuis,4 Steven Le Gouill,5 Marek Trněný6 1. Hospital of the Ludwig Maximilians University, Munich, Germany 2.Read More

Relapsed/Refractory Multiple Myeloma: The Current State of Play

Relapsed/Refractory Multiple Myeloma: The Current State of Play

July 30, 2015 at 9:01 AM 0 comments

*María-Victoria Mateos, Enrique M. Ocio, Verónica González, Julio Dávila University Hospital of Salamanca/IBSAL, Salamanca, Spain *Correspondence to mvmateos@usal.es Disclosure: María-Victoria Mateos has received honoraria for lectures and advisory boards from Janssen, Celgene, Novartis, Takeda, Amgen, and BMS. Enrique M. Ocio has received research support from Celgene, Amgen, Pharmamar, Array Pharmaceuticals,Read More

Iron Overload: Causes, Consequences, And Control

Iron Overload: Causes, Consequences, And Control

December 12, 2014 at 10:35 AM 0 comments

*Douglas P. Bentley Department of Pathology, Spire Cardiff Hospital, Cardiff, UK *Correspondence to dpbentley45@gmail.com Disclosure: No potential conflict of interest. Abstract The endeavours of physicians taxed with the problem of iron deficiency over the last 100 years have successfully eliminated this as an issue of hematological interest. Iron overload, althoughRead More